Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

Clinical trial NCT06851806 · RECRUITING

Trial details

NCT number: NCT06851806
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2025-12-10
Primary completion: 2027-02-28
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.